Vanniya S Paridhy, Chandru Jayasankaran, Pavithra Amritkumar, Jeffrey Justin Margret, Kalaimathi Murugesan, Ramakrishnan Rajagopalan, Karthikeyen Natarajan P, C R Srikumari Srisailapathy
Department of Genetics, Dr. ALM PG Institute of Basic Medical Science, University of Madras, Taramani, Chennai, India.
Current affiliation: Department of Biotechnology, Women's Christian College, Chennai, India.
Ann Hum Genet. 2018 Mar;82(2):119-126. doi: 10.1111/ahg.12228. Epub 2017 Nov 17.
Mutations in CDH23 are known to cause autosomal-recessive nonsyndromic hearing loss (DFNB12). Until now, there was only one study describing its frequency in Indian population. We screened for CDH23 mutations to identify prevalent and recurring mutations among South Indian assortative mating hearing-impaired individuals who were identified as non-DFNB1 (GJB2 and GJB6). Whole-exome sequencing was performed in individuals found to be heterozygous for CDH23 to determine whether there was a second pathogenic allele. In our study, 19 variants including 6 pathogenic missense mutations were identified. The allelic frequency of pathogenic mutations accounts to 4.7% in our cohort, which is higher than that reported previously; three mutations (c.429+4G>A, c.2968G>A, and c.5660C>T) reported in the previous Indian study were found to recur. DFNB12 was found to be the etiology in 3.4% of our cohort, with missense mutation c.2968G>A (p.Asp990Asn) being the most prevalent (2.6%). These results suggest a need to investigate the possibility for higher proportion of CDH23 mutations in the South Indian hearing-impaired population.
已知CDH23基因的突变会导致常染色体隐性非综合征性听力损失(DFNB12)。到目前为止,仅有一项研究描述了其在印度人群中的频率。我们对CDH23突变进行筛查,以确定在南印度选型婚配的听力受损个体(被确定为非DFNB1,即GJB2和GJB6)中普遍存在和反复出现的突变。对被发现为CDH23杂合子的个体进行全外显子组测序,以确定是否存在第二个致病等位基因。在我们的研究中,共鉴定出19种变异,包括6种致病性错义突变。在我们的队列中,致病突变的等位基因频率为4.7%,高于先前报道的频率;先前印度研究中报道的三种突变(c.429+4G>A、c.2968G>A和c.5660C>T)被发现反复出现。在我们的队列中,3.4%的病例病因是DFNB12,其中错义突变c.2968G>A(p.Asp990Asn)最为常见(2.6%)。这些结果表明,有必要研究南印度听力受损人群中CDH23突变比例较高的可能性。